* The growth of the Indian Pharma market has come down from 13.5 per cent in FY15 to 10 per cent YoY in FY18
* Analysts point out that growth from product introductions has nearly halved over the last two years as the drug regulator has been more stringent about new combination drugs
* Growing awareness about cheaper alternatives to branded generics and more channels providing access to them has started to impact volume growth for branded generics
* The Government's push towards Jan Aushadhi stores has started to impact volumes of branded generics
* The Pradhan